Retrospective analysis of treatement modalities and treament outcome in young high-risk patients aged <70 years with diffuse large b-cell lymphoma at Freiburg University CCCF Lymphomacenter.
- Conditions
- C83.3Diffuse large B-cell lymphoma
- Registration Number
- DRKS00009982
- Lead Sponsor
- Medizinische Klinik I - LymphomzentrumUniversitätsklinikum Freiburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 63
Inclusion Criteria
Age 18 – 70.
Primary DLBCL or grade 3b FL without clinical or radiological signs of CNS disease and cytology - CSF.
aaIPI 2-3
and/or
Site specific risk factors for CNS disease.
First-line therapy at University Freiburg Lymphoma Center
Exclusion Criteria
Clinical or radiological signs of CNS disease.
Positive CSF
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall response rate, complete-remission rate.
- Secondary Outcome Measures
Name Time Method Progression-free-, and overall-survival.